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INTRODUCTION:  Primary  malignant  melanoma  of  the gastrointestinal  tract  is very  rare,  especially  in the
stomach.  We  report  an  extremely  rare case  of  primary  malignant  melanoma  of  the esophagogastric
junction  mainly  situated  in  the  stomach.
PRESENTATION OF CASE:  The  patient was  a 72-year-old  woman  who  complained  of shortness  of  breath
due  to  severe  anemia.  Upper  endoscopy  revealed  a soft  easy-bleeding  polypoid  tumor  just  adjacent  to
the  esophagogastric  junction  in  the  stomach.  Biopsy  of  the  tumor  did  not  indicate  a deﬁnite  result,  except
malignant  tumor.  We  performed  total gastrectomy  with  splenectomy,  and  histological  and  immunohis-
tological  examination  revealed  malignant  melanoma  of  the  esophagogastric  junction.  She  had  no  remote
metastasis  or  lymphnodal  metastasis  at the  point  of  surgery;  however,  she  died  of  multiple  metastases
11  months  after  the  operation.
DISCUSSION: A  deﬁnite  preoperative  diagnosis  of  primary  malignant  melanoma  was  very difﬁcult  to make
from  the preoperative  biopsy  specimen.  This  present  case  was  ﬁrst  misinterpreted  as  undifferentiated
carcinoma,  or malignant  lymphoma.  Following  the  diagnosis  of malignant  melanoma,  the  question  arose
as  to  whether  this  was  primary  or metastatic  (as malignant  melanoma  from  other  sites  is known  to
metastasize  to  the  stomach).  Finally  this  tumor  was  diagnosed  as a primary  one  due  to the  pathologic
characteristics  such  as the  existence  of  junctional  activities.
CONCLUSION: We  report  an  extremely  rare  case  of  primary  malignant  melanoma  of  the esophagogastric
junction  present  in the  stomach.
© 2013 Surgical Associates Ltd. Published by Elsevier Ltd. Open access under CC BY-NC-ND license. . Introduction
Malignant melanoma is a tumor with highly malignant poten-
ial. Though the majority of the malignant melanomas arise
n the skin, other less common sites include the squamous
ucous membranes such as the esophagus, eyes, and lep-
omeninges. Primary malignant melanoma of the esophagus is
n extremely rare disease comprising approximately 0.1–0.2%
f all esophageal malignancies.1 Since biopsy specimens taken
rom the tumor often fails to identify the presence of malignant
elanoma, preoperative deﬁnite diagnosis of this tumor is fairly
ifﬁcult.
We herein present a rare case of primary malignantelanoma of the esophagogastric junction situated in the
tomach and also discuss the difﬁculties in diagnosing this
isease.
∗ Corresponding author. Tel.: +81 862507250; fax: +81 862507250.
E-mail  addresses: hca01333@nifty.com, hca01333@okayamah.rofuku.go.jp
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210-2612 ©  2013 Surgical Associates Ltd. Published by Elsevier Ltd. 
ttp://dx.doi.org/10.1016/j.ijscr.2013.04.037
Open access under CC BY2. Presentation of case
A  72-year-old woman  was  admitted to our hospital due to
shortness of breath on effort. Her past and family history was unre-
markable. She did not complain of digestive symptoms, such as
nausea or abdominal pain. Physical examination revealed marked
anemia of the conjunctiva, but the nutritional status was  not poor.
Blood cell counts showed severe anemia, with a hemoglobin con-
centration of 4.2 g/dl. Tumor markers, CEA and CA19-9 especially,
were within the normal range. Endoscopic examination showed a
large easy-bleeding polypoid tumor just adjacent to the esopha-
gogastric junction in the upper stomach (Fig. 1). Biopsy specimens
taken twice from the tumor failed to identify the presence of malig-
nant melanoma, suggesting it to be undifferentiated carcinoma or
malignant lymphoma.
Upper  GI examination using barium contrast showed a large
polypoid tumor in the upper stomach just beside the esophagogas-
tric junction (Fig. 2). Deformity of the stomach wall was too slight
to suspect gastric cancer. Contrast-enhanced CT (CE-CT) showed a
vascular-rich mass on the lesser curvature of the upper stomach
(Fig. 3). The extent of wall invasion was  diagnosed as the muscle
-NC-ND license. 
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Fig. 3. CE-CT showed a vascular-rich mass on the lesser curvature of the upper
stomach (arrows). No lymph nodal swelling or liver metastasis was noted.ig. 1. Endoscopic examination showed a large easy-bleeding polypoid tumor just
djacent to the esophagogastric junction in the upper stomach.
ayer of the stomach. There was no apparent lymphnodal swelling
r liver metastasis on CE-CT.
Since  the tumor was bleeding markedly, we decided to oper-
te without a diagnosis. Total gastrectomy with splenectomy was
erformed, including D2 lymph node resection. The tumor was  sit-
ated on the lesser curvature of the upper stomach, as shown by
ther investigations. No ascites or dissemination of the tumor was
bserved in the peritoneal cavity. Frozen sections of the esophageal
xcision stump revealed no malignant tumor cells. Reconstruction
as performed with the usual R-Y method.
The resected specimen revealed a polypoid tumor,
.7  cm × 8.1 cm in size, with partial black pigmentation, situ-
ted in the upper stomach (Fig. 4). The oral side of the tumor
as barely attached to the esophageal mucosa. Histological
xamination of the specimen showed large nests of anaplastic,
olymorphous tumor cells. At ﬁrst, the dark, brown pigmentation
as not noticed. The tumor invasion reached the muscles propria,
ig. 2. Upper GI examination using barium contrast showed a large polypoid tumor
n the upper stomach just beside the esophagogastric junction (arrows). No stenosis
f the esophagogastric junction was observed.
Fig. 4. Resected specimen of the whole stomach revealed a polypoid tumor,
6.7  cm × 8.1 cm in size, with partial black pigmentation, situated in the upper stom-
ach. The tumor is scarcely attached to the esophageal mucosa.
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Fig. 5. (A) H&E, (B) Masson-Fontana, (C) S-100, and (D) HMB-45.
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Immunohistological studies, such as S-100 protein(+) and HM
elanocytes with S-100 stain were observed (arrows).
ith lymphatic invasion without vascular invasion. No lymph
odal metastasis was found in the stomach regional lymph nodes.
ince the histological diagnosis was obscure, immunohistological
tudies were carried out and showed Fontana-Masson stain pos-
tive, HMB45 positive, S-100 protein positive. In addition, EMA
egative, cytokeratin20 negative, and cytokeratin7 negative led
s to the diagnosis of malignant melanoma. Close pathological
xamination of the mucosa of the distal end of the esophagus
evealed the junctional activities of atypical melanocytes (Fig. 5).
Post-operatively, further examinations were performed to
ssess whether the tumor was metastasis or a primary tumor.
xamination of the whole body skin was performed by a der-
atologist, but revealed no pigmented region of the skin, and
he retinas on both sides were examined by an ophthalmologist,
ut no suspicious primary lesion was found. PET (positron emis-
ion tomography)–CT was carried out to ﬁnd other tumors which
ere the original focus or other metastases, but no hot spot was
etected. These results implied a ﬁnal diagnosis of primary malig-
ant melanoma of the esophagogastric junction.
Systemic adjuvant chemotherapy was offered due to the aggres-
ive potential of malignant melanoma, but the patient declined.
he post-operative course was smooth for the ﬁrst 3 months. CE-
T after 3 months showed no remote metastasis or any abnormal
ndings; however, 5 months after the operation, the patient was
dmitted because of left back pain, and CE-CT revealed metastatic
umor of malignant melanoma of the left adrenal gland with a
leeding mass around the left kidney as well as severe anemia. We
ere planning to operate immediately after admission, but as the
ain from the bleeding mass stabilized, she rejected surgery.
Nine  months after the operation, she developed left axillary
ymph node metastases, and a subcutaneous metastatic tumor just(+), conﬁrmed the diagnosis of malignant melanoma. Junctional activities of atypical
right of the navel. At 10 months after the operation, metastatic
tumors in the thoracic cavity and abdomen were newly found,
she developed renal failure due to adrenal metastases, and died
11 months after the stomach operation.
3. Discussion
Malignant melanoma commonly originates from the skin
and has a high grade of malignancy. It is rarely seen in the
gastrointestinal tract, but primary esophageal and rectal malig-
nant melanomas are reported sporadically. In particular, primary
malignant melanoma of the esophagus is an extremely rare
disease comprising approximately 0.1–0.2% of all esophageal
malignancies.1 In Japan, Yamaguchi reported a case of primary
malignant melanoma and investigated 193 cases of primary malig-
nant melanoma of the esophagus reported in Japan. According to
his report, men  predominated the cases by 2.2:1, with an overall
mean age of 60.4 (21–89). The common symptoms were dysphagia
(64.2%) and chest pain (9.3%), but 7.3% of the patients had no symp-
toms. The tumors were usually located in the middle and lower
third of the esophagus (76.2%) and usually show a polypoid shape,
and pigmentation.2
In our case, we  observed no tumors in the esophagus lumen
and the center of the tumor was in the upper stomach. Various dif-
ferential diagnoses were considered beside malignant melanoma,
because the tumor was  found in the stomach. An accurate pre-
operative diagnosis of primary malignant melanoma was very
difﬁcult to make from the preoperative biopsy specimen which
was ﬁrst misinterpreted as undifferentiated carcinoma, or malig-
nant lymphoma. Other authors have also referred to the difﬁculty
of diagnosing preoperative biopsy specimens.3,4
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After the operation, immunohistochemical examinations led us
o the diagnosis. In particular, S-100 protein, HMB-45 and Vimentin
ere positive with cytokeratin negative, so we could make a deﬁni-
ive diagnosis.5,6
After the deﬁnite diagnosis of the malignant melanoma, the
nique situation of the tumor made us wonder whether this tumor
s primary or metastatic. Malignant melanoma in the stomach
s usually metastatic, primary gastric malignant melanoma being
xtremely rare. A series of autopsies of patients with melanoma
evealed gastric metastasis rates of more than 22%.7 The diagnostic
riteria for deciding whether the lesion is a primary or metastatic
umor were described by Raven and Dawson,8 based on the pro-
osals of Allen and Spitz.9 They said that the tumor should have
he structure of a melanoma, contain melanin granules and, most
mportantly, should arise from an area of junctional change within
he squamous mucosa and that the adjacent epithelium should also
how nests of atypical melanocytes with pleomorphic nuclei, called
unctional changes; however if the tumor grows rapidly, sometimes
he adjacent junctional changes might not be seen. Unfortunately
his major criterion is met  in only approximately 40% of cases.10
f the major criterion is not met, other clinical factors, such as
he absence of other primary sites of melanoma, and no history
f removal of melanoma or an atypical melanocytic lesion from
he skin or other organs should be signiﬁcant.11 However, as the
athology of this tumor showed junctional activities of atypical
elanocytes in the mucosa of the distal esophagus, a deﬁnitive
iagnosis of primary esophageal malignant melanoma was  made.
o history of skin or retinal melanoma, and a negative PET scan of
he primary site conﬁrmed this. As FDG-PET was reported to have
he advantage of ﬁnding metastasis of malignant melanoma,12 this
nformation is strongly supportive of the primary melanoma.
Primary gastric malignant melanoma is extremely rare and only
 few cases have been reported.13,14 However, in our case, it is likely
hat the tumor arose from the esophageal mucosa of the esoph-
gogastric junction given all the pathological ﬁndings, especially
unctional activity. From all these considerations, we diagnosed this
umor as an extremely rare case of primary malignant melanoma
f the esophagogastric junction which arose at the distal end of the
sophagus and mainly extended into the stomach.
This is generally considered a highly malignant tumor which
arries a poor prognosis with a rapidly fatal course. The present
ase died of the systemic spread of the disease only 11 months
fter surgery. Sabanathan et al. reported that the average overall
urvival of patients was 9.8 months and 5-year survival rate was
nly 1.69%.1 But Volpin et al. reported the better 5-year survival
ate as 37%.15 Yamaguchi et al. reported the 5-year survival rate as
0% in a Japanese series in 2004. Their multivariate analysis with
ox’s proportional hazard model showed that the most signiﬁcant
rognostic factor was the depth of tumor invasion.2
We  regret that no adjuvant chemotherapy was  given to the
atient. Some researchers have mentioned the advantages of DAV
dacarbazin, nimustine, vincristine)13 or immunotherapy,14 but
thers found no effect against widespread metastasis and the poor
rognosis of malignant melanoma.3 Consequently, there are no def-
nite adjuvant chemotherapies. While in the near future, effective
ystemic chemotherapy can be expected to further improve the
urvival rate..  Conclusion
We  report an extremely rare case of malignant melanoma of
he esophagogastric junction situated in the stomach, and suggest
1PEN  ACCESS
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that  doctors should be aware that malignant melanoma (whether
primary or secondary) can occur in the gastro-intestinal tract. Given
its poor prognosis, there is a need for more effective multimodal
therapy.
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